Latest filing published 25 Sept 2018 for CEREBAIN BIOTECH CORP., €23k.
Insider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Eric Clemons: trading record in brief
Eric Clemons has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Cerebain Biotech Corp. and GTC Telecom Corp. Over a trading history stretching from 23 April 2007 to 19 February 2018, the count stands at 10 filings.
Purchases make up the whole of the open-market record (1 purchase, €88k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 5 share grants and 4 option exercises.
The record was last updated on 25 September 2018 with a share grant (€23k) in Cerebain Biotech Corp. The last insider purchase was made public on 30 June 2014, 4,514 days ago. The median gap between a trade and its publication by SEC (Form 4) is 6 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Eric Clemons
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 160,000 shares@ US$0.18100.0% of flowCommon StockSEC:0001435164-18-000002:0
- 150,000 shares@ US$0.2761.6% of flowCommon StockSEC:0001582945-16-000011:0
- 380,625 shares@ US$3,806.25Common StockSEC:0001582945-15-000002:0
- 250,000 shares@ US$0.31Common StockSEC:0001582945-15-000002:1
- 48,435 shares@ US$1.50Common StockSEC:0001582945-14-000007:0
- 80,677 shares@ US$1.50Common StockSEC:0001582945-14-000006:0Canonical exit: 31 Mar 2014 (T+90)
- 34,000 shares@ US$0.19commonSEC:0001081919-07-000004:1
- 120,000 shares@ US$0.10commonSEC:0001081919-07-000004:2
8 of 8 declarations